Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents

Status Completed

Clinical Trial Summary

The objective of the study was to evaluate the diagnostic performance and safety of T.R.U.E. Test allergens in pediatric subjects aged 6-17 years old. In total, 11 allergens were evaluated; 7 new allergens on panels 2.2 and 3.2 and 4 previously approved allergens for which changes were made to dose and excipient.

Clinical Trial Description

The evaluation of 7 new allergens on panels 2.2 and 3.2, Gold sodium thiosulfate, Hydrocortisone-17-butyrate, Bacitracin, Parthenolide, Methyldibromoglutaronitrile, Disperse blue 106, and Bronopol was the original objective of the study. The protocol was amended to include evaluation of 4 reformulated allergens; neomycin sulfate, potassium dichromate, ethylenediamne dihydrochloride and fragrance mix. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01797562
Study type	Interventional
Source	Allerderm
Contact
Status	Completed
Phase	N/A
Start date	December 10, 2012
Completion date	September 8, 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03945760` - Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects	Early Phase 1
Not yet recruiting	`NCT05498467` - The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis	Phase 3
Active, not recruiting	`NCT03680131` - Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis	Phase 2
Recruiting	`NCT05535738` - Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation	Phase 2/Phase 3
Recruiting	`NCT06191627` - Patient Experience and Quality of Patch Testing on the Legs vs Back	N/A
Completed	`NCT00867607` - Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis	Phase 1/Phase 2
Recruiting	`NCT00445029` - Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation	N/A
Completed	`NCT04365140` - MicroRNA-126 and Its Target VCAM-1Dermatitis to Nickel
Recruiting	`NCT05991674` - A Prospective Study to Investigate Contact Sensitization Using Classic and Machine Learning Techniques
Completed	`NCT00931242` - Study of Apremilast in Atopic or Contact Dermatitis	Phase 2
Completed	`NCT01798589` - Bioequivalence of Ethylenediamine Dihydrochloride Study	Phase 4
Completed	`NCT01546298` - Immune Reactions in Contact Dermatitis Affected Skin
Completed	`NCT05339750` - Allergy Skin Patch Artificial Intelligence (AI)	N/A
Recruiting	`NCT03935971` - The Effects of Dupilumab on Allergic Contact Dermatitis	Phase 4
Not yet recruiting	`NCT05858723` - Repeated Open Application Test (ROAT) Study With Hydroperoxides of Linalool	N/A
Completed	`NCT02534441` - Epidemiology and Co-Reactivity of Novel Surfactant Allergens	N/A
Not yet recruiting	`NCT01413477` - Nickel Desensitization Using Topical Therapy	N/A
Completed	`NCT00132600` - Clinical Evaluation of Bacitracin	Phase 2
Completed	`NCT00133341` - Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate	Phase 2
Completed	`NCT03902392` - Red Grape Polyphenol Oral Administration to Women Affected by Nickel-mediated Allergic Contact Dermatitis	N/A